CD8A and colonic neoplasm: The Immunoscore® was developed to evaluate the presence of immune infiltrates in the TME of colon cancer patients and to enable the assessment of the density, location, and types of different immune infiltrate cells such as total T cells (CD3+), cytotoxic T cells (CD8+) in the CT, and the IM.